Replies to post #15107 on Oncolix Inc. (fka ONCX)

[BLight1911]

I would say a successful Phase 1 is very likely in my opinion. With the share structure this could easily be trading well over $1 per share in the near future. Claims that the Oncolix CEO is "in hiding" are 100% nonsense. His home address is on many of the filings. Not sure where any of that BS comes from.

[Bored Lawyer]

Nice substantive post. Refreshing!

From these prices, the Phase I results are really all that matter to determine if we'll make some money or not here.

Over the period 2006-2015, 63% of oncology drugs in FDA trials moved from Phase I to Phase II (see page 9).

https://www.bio.org/sites/default/files/Clinical%20Development%20Success%20Rates%202006-2015%20-%20BIO,%20Biomedtracker,%20Amplion%202016.pdf

Even better, drugs with ODD (like Prolanta) have a Phase I to Phase II approval rate of closer to 75%.

http://www.raredr.com/news/orphan-approval

Based on what we know already about Prolanta, my opinion is the likelihood of Prolanta moving on to Phase II is at least that high.

I won't speculate on PPS if/when we get news of successful Phase I, but I expect, even with additional dilution, that it will be trading substantially north of here. Agree re: huge potential upside.

Good luck to all.